Pyxis Oncology Files Prospectus For Offering 39.2M Common Shares On Behalf Of Selling Shareholders
https://www.sec.gov/Archives/edgar/data/1782223/000119312526359246/pyxs-20260820.htm
Read original at benzingaStocks · News reference
8-K filing — Pyxis Oncology, Inc. (PYXS)
Filed: 2026-08-13 AccNo: 0001193125-26-347911 Size: 492 KB Item 2.02: Results of Operations and Financial Condition
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 13, 2026, 11:42 AM
- Checked
- Aug 13, 2026, 11:42 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $7 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Pyxis Oncology (NASDAQ:PYXS) with a Buy and maintains $7 price target.
Read original at benzingaPyxis Oncology Q2 EPS $(0.40) Misses $(0.35) Estimate
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.35) by 14.29 percent. This is a 33.33 percent decrease over losses of $(0.30) per share from
Read original at benzinga